Page 3 - Gbola Amusa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gbola amusa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gbola Amusa Today - Breaking & Trending Today

Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation


Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
Equity Performance: from Sonic Fund letter to Adverum
Equity Performance: from Sonic Fund letter to Adverum
Image 1: from Sonic Fund letter to Adverum
Image 1: from Sonic Fund letter to Adverum
Image 2: from Sonic Fund letter to Adverum
Image 2: from Sonic Fund letter to Adverum
Image 3: from Sonic Fund letter to Adverum
Image 3: from Sonic Fund letter to Adverum
Image 4: from Sonic Fund letter to Adverum
Image 4: from Sonic Fund letter to Adverum
Image 5: from Sonic Fund letter to Adverum
Image 5: from Sonic Fund letter to Adverum ....

United States , North Carolina , Redwood City , San Francisco , University Of Southern California , University Of Pennsylvania , Jeff Heier , Mehdi Gasmi , Patrick Machado , Gabrielle Wolf , Tom Woiwode , Pravin Dugel , Aaron Osborne , Joele Frank , Laurent Fischer , Jodi Cook , Agilis Biotherapeutics , Angela Thedinga , Iveric Bio , Jeff Bezos , Myesha Lacy , Christopher Derespino , Los Angeles , Tjean Bennett , Reed Tuckson , Gensight Biologics ,

ophthalmology


Gbola Amusa, Chardan Capital Markets head of healthcare research, commented in a note on Monday that investors should be more selective in the biotech space. As such, the analyst downgraded shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) to Neutral from Buy with an unchanged $565 price. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

Gbola Amusa , Wedbush David Nierengarten , Mark Baum , David Nierengarten , Regeneron Pharmaceuticals Inc , Spark Therapeutics Inc , Ocular Therapeutix Inc , Imprimis Pharmaceuticals Inc , Chardan Downgrades Regeneron Pharmaceuticals , Health Care , Homology Medicines Inc , Medicines Inc , Spark Therapeutic , Therapeutics Inc , Analyst Wedbush , Phenomenal Quarter , Shocking Statistics , Simplification And , Trifecta For Successthursday , Pharmaceuticals Inc , San Diego Based , Analyst Color , Long Ideas , Chardan Capital Markets , Downgrades Regeneron Pharmaceuticals , Notes Valuation Concernsmonday ,

Gene Editing


Shares of Calyxt Inc (NASDAQ: CLXT) gained more than 7 percent Monday after analysts at BMO Capital Markets initiated coverage of the food and agriculture company with a bullish rating. The firm s Kenneth Zaslow slapped an Outperform rating on Calyxt s stock with a $32 price target.
Calyxt is. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

Madhu Kumar , Gbola Amusa , Kenneth Zaslow , Cynthia Collins , Precision Biosciences Inc , Food Companies , Calyxt Inc , Drug Administration , Intellia Therapeutics Inc , Vertex Pharmaceuticals Incorporated , Cytovia Therapeutics Inc , Editas Medicine Inc , Health Care , Gene Editing , Editing Platform Is Safe , Long Term Animal Study Showsfriday , Biosciences Inc , Small Cap , Therapeutics Inc , Natural Killer , Chimeric Antigen Receptor , Gene Editing Scientist Gets , What Happened , Preclinical Data Inspires , Analyst Madhu Kumar , Intellia Therapeutics ,

Biotech startup acquisitions jumped in 2020, leaving VCs optimistic for New Year


Biotech startup acquisitions jumped in 2020, leaving VCs optimistic for New Year
Premium
Bayer announced its deal to buy gene-therapy startup Asklepios BioPharmaceutical in October, one of 19 acquisitions of biotech startups by drug manufacturers last year, according to Silicon Valley Bank.
(REUTERS)
Brian Gormley
Share Via
Read Full Story
Acquisitions of biotechnology startups jumped in 2020, as buyers moved upstream to grab promising drugmakers while they were still private and relatively cheap.
Drug manufacturers bought 19 biotech startups last year, up from 15 in 2019, according to Silicon Valley Bank. Last year’s total was the highest since the 20 buyouts recorded in 2016. The median upfront sum paid in 2020 was $300 million, compared with $250 million the year before. ....

Jonathan Norris , Gbola Amusa , Narendra Modi , Randeep Guleria , Otello Stampacchia , Christiana Bardon , David Lee , Celsius Therapeutics Inc , Silicon Valley Bank , Bayer Ag , Capital Oncology Impact Fund , Chardan Capital Markets , Servier Pharmaceuticals , Agios Pharmaceuticals Inc , Asklepios Biopharmaceutical Inc , Silicon Valley , Minister Narendra Modi , Director Jonathan Norris , Asklepios Biopharmaceutical , Servier Laboratories , Agios Pharmaceuticals , Oncology Impact Fund , Big Pharma , Omega Funds , Join Mint , Biotechnology Firms Ipo ,